NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.

Don't have an account? Subscribe

Possible sildenafil reclassification in Ireland

By Mindo - 10th Jan 2018

“Pfizer is exploring a number of opportunities to expand access to medications via reclassification to non-prescription status,” a spokesperson for the company told the <strong><em>Medical Independent</em></strong> (<strong><em>MI</em></strong>).

In the UK, Viagra Connect tablets are being reclassified as a non-prescription pharmacy medicine for the treatment of the symptoms of ED in men aged 18 years and over.

“The benefits of making Viagra Connect available to men with ED are not limited to the UK market and we are exploring other markets where this may be possible,” a Pfizer spokesperson told <strong><em>MI</em></strong> when asked whether it is considering making an application for Viagra to be reclassified in Ireland.

The Health Products Regulatory Authority (HPRA) told <strong><em>MI</em></strong> that it is not in a position to say whether it has received any application to change the current prescription-only classification of sildenafil to make it available OTC “due to commercial sensitivities”.

“The HPRA welcomes applications for innovative reclassifications, and provides guidance on its website,” the HPRA spokesperson told <strong><em>MI</em></strong>.

Counterfeit and illegal ED drugs are among the most common detained medicinal products by the HPRA and Customs every year and supporters of reclassifying sildenafil say making it available OTC could help alleviate the issue.

Leave a Reply

Latest Issue
The Medical Independent 20th February
The Medical Independent 20th February 2024

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read